INSTRUCTIONS Speak the language of autism
* To take the test online, go to our secure Web site at http://www.nursingcenter.com/ce/NP.
* On the print form, record your answers in the test answer section of the CE enrollment form on page 34. Each question has only one correct answer. You may make copies of these forms.
* Complete the registration information and course evaluation. Mail the completed form and registration fee of $24.95 to: Lippincott Williams & Wilkins, CE Group, 2710 Yorktowne Blvd., Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
* You will receive your CE certificate of earned contact hours and an answer key to review your results. There is no minimum passing grade.
* Registration deadline is April 30, 2012.
DISCOUNTS and CUSTOMER SERVICE
* Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together and deduct $0.95 from the price of each test.
* We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Williams & Wilkins, publisher of The Nurse Practitioner journal, will award 2.8 contact hours for this continuing nursing education activity.
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.8 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454.
Your certificate is valid in all states.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
Speak the language of autism
General Purpose: To provide NPs with current information about the diagnosis and management of autism. Learning Objectives: After reading the article and taking this test, the NP should be able to: 1. Explain the prevalence, characteristics, and epidemiology of autism. 2. Identify tools and criteria for diagnosing autism. 3. Describe options for managing autism.
1. The percentage of autistic children with an average IQ or better is approximately
2. Autism usually manifests between ages
a. 0 to 6 months.
b. 12 to 24 months.
c. 3 to 4 years.
d. 5 to 6 years.
3. U.S. data from 2007 showed the incidence of 8-year-olds with ASD was 1 in
4. The NIH concurred that autism is hereditary, due to evidence
a. that if one identical twin is autistic, the second has a 90% chance of it.
b. of transmission on the X chromosome.
c. of a male-to-female incidence ratio of 2:1.
d. of single gene involvement.
5. Gene variation in families with more than one autistic child has been found on
a. chromosome 1.
b. chromosome 3.
c. chromosome 5.
d. chromosome 7.
6. In mice, two genes were identified to influence autistic-like symptoms, such as
a. communication difficulties.
b. sociability difficulties.
c. difficulty playing with toys.
d. over-focusing on shiny objects.
7. In a study using MRI scans, autistic children ages 2 to 4 were found to have
a. larger than normal brain volume.
b. smaller than normal brain volume.
c. decreased cerebral gray and white matter.
d. decreased cerebral gray matter and increased white matter.
8. Vaccine experts for the AAP and the CDC agree that the MMR vaccine
a. is weakly linked to rising rates of autism.
b. is a significant cause of autism.
c. is not responsible for the rise in autism diagnoses.
d. is one of the multifactorial causes of autism.
9. One of the earliest and most important signs of autism is
a. continual repetition.
b. fear of loud noises.
c. preoccupation with certain objects.
d. failure to develop joint attention.
10. The CARS tool
a. has a reliability for total scores of 0.68.
b. is the most widely used diagnostic tool for autism.
c. rates children on 18 items to detect signs of autism.
d. was developed to monitor infants for signs of autism.
11. The "gold standard" for diagnosing autism is
a. clinical judgment with use of DSM-IV criteria.
b. MRI results in combination with the CARS tool.
c. agreement between two diagnostic tools that detect autism.
d. consistent test and retest results using the same valid tool.
12. The ADI-R tool
a. utilizes child caregiver feedback.
b. has a diagnostic stability of 83%.
c. is a semistructured, clinician-based interview.
d. uses observational data for diagnosis in early childhood.
13. Early intervention programs for children with autism
a. have been found to be ineffective.
b. are programs based on peer interactions.
c. should be based on each child's strengths and weaknesses.
d. provide treatment in a group setting environment.
14. Applied behavior analysis
a. includes 40 hours per week of therapy.
b. claims to decrease autism severity by 42%.
c. is an intensive, home-based behavioral program.
d. involves teacher and child working together on play and life skills.
15. Using home-based behavioral therapy in a U.K. study, the group PEACH
a. benefited from cooperation from schools.
b. integrated the Lovaas program in each home.
c. found the majority of the children responded positively.
d. found behavior improvement in less than 10% of the children.
16. A study evaluating a casein- and gluten-free diet for autistic children showed
a. no statistical difference.
b. improved sociability.
c. the children could not tolerate the diet.
d. increased hyperactivity and tantrums.
17. Which medication is FDA-approved to treat irritability in specific autistic children?
18. At the time of autism diagnosis, the NP's role is to
a. provide anticipatory guidance.
b. determine the child's outcome.
c. identify the child's future disabilities.
d. explain the curative treatments used for autism.
© 2010 Lippincott Williams & Wilkins, Inc.